121 related articles for article (PubMed ID: 10163555)
1. Extracorporeal granulocytapheresis for cancer and rheumatoid arthritis.
Yonekawa M; Kawamura A; Komai T; Agishi T; Adachi M
Transfus Sci; 1996 Sep; 17(3):463-72. PubMed ID: 10163555
[TBL] [Abstract][Full Text] [Related]
2. Granulocytapheresis as a possible cancer treatment.
Tabuchi T; Ubukata H; Sato S; Nakata I; Goto Y; Watanabe Y; Hashimoto T; Mizuta T; Adachi M; Soma T
Anticancer Res; 1995; 15(3):985-90. PubMed ID: 7645990
[TBL] [Abstract][Full Text] [Related]
3. Granulocytapheresis in the treatment of patients with rheumatoid arthritis.
Ohara M; Saniabadi AR; Kokuma S; Hirata I; Adachi M; Agishi T; Kasukawa R
Artif Organs; 1997 Sep; 21(9):989-94. PubMed ID: 9288869
[TBL] [Abstract][Full Text] [Related]
4. Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1.
Fujimori J; Yoshino S; Koiwa M; Hirai H; Shiga H; Hayama N; Iino Y
Rheumatol Int; 1996; 15(5):175-80. PubMed ID: 8717100
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study.
Nagashima M; Yoshino S; Tanaka H; Yoshida N; Kashiwagi N; Saniabadi AR
Rheumatol Int; 1998; 18(3):113-8. PubMed ID: 9833252
[TBL] [Abstract][Full Text] [Related]
6. Granulocytapheresis in patients with refractory ocular Behcet's disease.
Namba K; Sonoda KH; Kitamei H; Shiratori K; Ariyama A; Iwabuchi K; Onoé K; Saniabadi AR; Inaba S; Ishibashi T; Ohno S
J Clin Apher; 2006 Jul; 21(2):121-8. PubMed ID: 16395727
[TBL] [Abstract][Full Text] [Related]
7. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
[TBL] [Abstract][Full Text] [Related]
8. [Dynamics of granulocyte proteins after lymphocytapheresis in patients with rheumatoid arthritis].
Shevchenko OP; Dubrovina NA; Pashkovskaia IA; Kalinin NN; Merkulov AG
Revmatologiia (Mosk); 1989; (3):3-6. PubMed ID: 2609058
[TBL] [Abstract][Full Text] [Related]
9. Current topics on cytapheresis technologies.
Yamaji K; Tsuda H; Hashimoto H
Ther Apher; 2001 Aug; 5(4):287-92. PubMed ID: 11724514
[TBL] [Abstract][Full Text] [Related]
10. Preliminary studies for the development of a second generation granulocytapheresis (G-CAP) column.
Miyamoto H; Sugita Y; Motomura T; Ohta K; Nosé Y
J Artif Organs; 2010 Jul; 13(2):92-6. PubMed ID: 20364286
[TBL] [Abstract][Full Text] [Related]
11. Flare up of ulcerative colitis during pregnancy treated by adsorptive granulocyte and monocyte apheresis: therapeutic outcomes in three pregnant patients.
Takahashi H; Sugawara K; Sugimura M; Iwabuchi M; Mano Y; Ukai K; Tadokoro K
Arch Gynecol Obstet; 2013 Aug; 288(2):341-7. PubMed ID: 23404436
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
Kanke K; Nakano M; Hiraishi H; Terano A
Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
[TBL] [Abstract][Full Text] [Related]
13. Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis.
Umekita K; Hidaka T; Ueno S; Takajo I; Kai Y; Nagatomo Y; Sawaguchi A; Suganuma T; Okayama A
Mod Rheumatol; 2009; 19(3):265-72. PubMed ID: 19337689
[TBL] [Abstract][Full Text] [Related]
14. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis.
Kashiwagi N; Hirata I; Kasukawa R
Ther Apher; 1998 May; 2(2):134-41. PubMed ID: 10225715
[TBL] [Abstract][Full Text] [Related]
15. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
[TBL] [Abstract][Full Text] [Related]
16. Leukocytapheresis in rheumatoid arthritis.
Hidaka T; Hashiba Y; Kubo K; Kai Y; Maeda K
Transfus Apher Sci; 2017 Oct; 56(5):698-702. PubMed ID: 28918917
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte apheresis as a possible new approach in cancer therapy: A pilot study involving two cases.
Tabuchi T; Ubukata H; Saniabadi AR; Soma T
Cancer Detect Prev; 1999; 23(5):417-21. PubMed ID: 10468894
[TBL] [Abstract][Full Text] [Related]
18. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
[TBL] [Abstract][Full Text] [Related]
19. Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis.
Okubo K; Yoshizawa K; Okiyama W; Kontani K; Muto H; Umemura T; Ichijo T; Matsumoto A; Tanaka E; Hora K; Shimodaira S; Kiyosawa K
Intern Med; 2006; 45(3):155-8. PubMed ID: 16508230
[TBL] [Abstract][Full Text] [Related]
20. A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.
Okuma K; Mitsuishi K; Hasegawa T; Tsuchihashi H; Ogawa H; Ikeda S
Ther Apher Dial; 2007 Oct; 11(5):387-90. PubMed ID: 17845399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
